S 3128 New Jersey Senate · 2024-2025 Regular Session

Requires health benefits plans to cover abuse-deterrent opioid analgesic drug products.

This bill requires New Jersey health insurance plans (carriers) to cover at least one abuse-deterrent opioid pain medication per active ingredient on their prescription formulary. It mandates that cost-sharing (like copays) for these abuse-deterrent drugs cannot exceed the lowest cost-sharing for similar non-abuse-deterrent opioids. The bill also prohibits requiring patients to try non-abuse-deterrent opioids first before accessing abuse-deterrent options. This applies to all health benefits plans delivered, issued, or renewed in New Jersey after the 90-day effective date following enactment.
Bill status in committee 1 of 4 stages cleared
Introduction
Apr 2024
Committee Review
Floor Vote
Governor
Introduced Apr 15, 2024 Last action Apr 15, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Apr 15, 2024
Introduced
Introduced in the Senate, Referred to Senate Commerce Committee
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Brian Stack
Brian Stack
DDemocratic
NJ
33